GlobeImmune Inc (OTCMKTS:GBIM)’s stock price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.09 and traded as low as $0.07. GlobeImmune shares last traded at $0.12, with a volume of 5,300 shares.
The company has a fifty day moving average price of $0.09 and a two-hundred day moving average price of $0.08.
About GlobeImmune (OTCMKTS:GBIM)
GlobeImmune, Inc, a biopharmaceutical company, focuses on developing therapeutic products for cancer and infectious diseases based on proprietary Tarmogen platform. Its product candidate includes GS-4774, which is in Phase 2 trials for the treatment of patients with chronically infected with hepatitis B virus, as well as with oral antiviral suppressive therapy.
Featured Story: What is a balanced fund?
Receive News & Ratings for GlobeImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlobeImmune and related companies with MarketBeat.com's FREE daily email newsletter.